Amir Arfaei, MD
Pulmonary Disease · Ventura
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 32 years
- Graduated 1994
Offices
1 location · Ventura Pulmonary and Critical Care Medical Group · 7 clinicians in this group
Looking this up.
Hospitals listed: Community Memorial Hospital - Ojai · Community Memorial Hospital - Ventura. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arfaei’s office at (805) 653-6371 to ask if they take your plan before you enroll.
California Medical Board record
Licence A102199 · Current
Licensed to practise in California · since 2007 · expires 2027-03-31 · Tehran University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Pulmonary Disease
- American Board of Internal Medicine - Sleep Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Memorial Hospital - OjaiOjai, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Community Memorial Health System, which runs 2 hospitals82% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Community Memorial Hospital - VenturaVentura, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Memorial Health System, which runs 2 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.478, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Memorial Hospital - Ojai
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 28 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 74 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -36.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Community Memorial Hospital - Ventura
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.95) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.49 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.27 (93.9 to 200.65) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,592 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,976 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.57 to 5.64) · 1,733 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.97 (1.53 to 4.4) · 1,669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.87 (1.2 to 14.54) · 661 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.35 to 8.61) · 686 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.93) · 3,678 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 218 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.157 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.228 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 249 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.8 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.6 · 357 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.1 to 13) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.7) · 1,178 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 986 cases | No different | Jan 2024 – Dec 2024 |
What patients said (949 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$145,942
Medicare paid this office $145,942 for 515 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 239 | $45,723 | $100 |
| Critical care, first 30-74 minutes | 59 | $16,964 | $170 |
| Long return visit (40+ min) | 82 | $15,327 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $15,263 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $9,827 | $133 |
See all 14 services
| Return visit (30+ min) | 239 | $45,723 | $100 |
| Critical care, first 30-74 minutes | 59 | $16,964 | $170 |
| Long return visit (40+ min) | 82 | $15,327 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $15,263 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $9,827 | $133 |
| New patient visit (60+ min) | 56 | $9,188 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $8,131 | $63 |
| Test to measure rate of airflow | 113 | $4,659 | $33 |
| Test to examine how well the lungs exchange gases | 80 | $4,240 | $48 |
| Test to determine lung volumes using sensors | 66 | $3,482 | $48 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 54 | $1,891 | $35 |
| Sleep study in sleep lab (6 years or older) | 15 | $1,443 | $96 |
| Short return visit (20+ min) | 18 | $1,327 | $74 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,191 | $66 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | – | – | – | – | – |
| Insertion of tube into vena cava | 11 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
515 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 15% · Women 50% · Also on Medicaid 18% · Health risk score 2.04. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Atrial fibrillation 42% · COPD 41% · Heart failure 39% · Depression 35% · Diabetes 34% · Chronic kidney disease 33% · Cancer 22% · Stroke 16% · Dementia 11%.
The office billed $240,969, Medicare allowed $193,220 and paid $145,942; for 1,596 services of 39 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 515 | 1,596 | 76 | 2.04 | $240,969 | $145,942 |
| 2023 | 454 | 1,329 | 75 | 1.85 | $208,728 | $126,479 |
| 2022 | 403 | 1,176 | 75 | 1.84 | $183,757 | $113,060 |
| 2021 | 399 | 1,263 | 75 | 1.78 | $190,638 | $119,416 |
| 2020 | 388 | 1,165 | 74 | 2.09 | $188,341 | $103,551 |
| 2019 | 449 | 1,637 | 75 | 2.23 | $213,037 | $138,857 |
| 2018 | 390 | 1,549 | 75 | 2.14 | $200,130 | $130,009 |
| 2017 | 420 | 1,570 | 75 | 1.98 | $198,025 | $130,816 |
| 2016 | 393 | 1,439 | 74 | 2.08 | $174,481 | $117,528 |
| 2015 | 422 | 1,592 | 75 | 1.94 | $200,025 | $135,469 |
| 2014 | 416 | 1,540 | 75 | 2.03 | $212,033 | $133,706 |
| 2013 | 348 | 1,503 | 75 | 2.02 | $165,054 | $116,038 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 214 | $37,969 | $99 |
| Critical care, first 30-74 minutes | 59 | $17,384 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $14,839 | $98 |
| Long return visit (40+ min) | 58 | $10,555 | $143 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $10,503 | $140 |
| New patient visit (60+ min) | 51 | $8,897 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $6,339 | $64 |
| Test to measure rate of airflow | 117 | $4,139 | $33 |
| Test to examine how well the lungs exchange gases | 78 | $3,850 | $49 |
| Test to determine lung volumes using sensors | 64 | $3,177 | $49 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,202 | $60 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 32 | $1,192 | $37 |
2022: 15 services
| Return visit (30+ min) | 200 | $32,615 | $99 |
| Critical care, first 30-74 minutes | 58 | $18,157 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $11,872 | $88 |
| Long return visit (40+ min) | 64 | $11,261 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,885 | $171 |
| New patient visit (60+ min) | 38 | $6,221 | $164 |
| Test to measure rate of airflow | 103 | $3,944 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,866 | $60 |
| Test to examine how well the lungs exchange gases | 69 | $3,646 | $49 |
| Test to determine lung volumes using sensors | 52 | $2,634 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $2,043 | $60 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 13 | $1,380 | $106 |
| Short return visit (20+ min) | 16 | $1,169 | $65 |
| Sleep study in sleep lab (6 years or older) | 11 | $1,134 | $103 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 13 | $476 | $37 |
2021: 13 services
| Return visit (30+ min) | 203 | $37,506 | $105 |
| Critical care, first 30-74 minutes | 37 | $11,540 | $186 |
| New patient visit (60+ min) | 61 | $10,456 | $171 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $9,994 | $167 |
| Long return visit (40+ min) | 54 | $9,501 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $9,463 | $89 |
| Test to examine how well the lungs exchange gases | 78 | $4,940 | $55 |
| Test to measure rate of airflow | 116 | $4,905 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $4,263 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 58 | $3,676 | $57 |
| Test to determine lung volumes using sensors | 66 | $3,576 | $50 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $2,895 | $103 |
| Sleep study in sleep lab (6 years or older) | 13 | $1,343 | $103 |
2020: 16 services
| Return visit (30+ min) | 177 | $24,731 | $83 |
| Critical care, first 30-74 minutes | 69 | $19,331 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $14,167 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $7,571 | $165 |
| New patient visit (60+ min) | 44 | $7,386 | $168 |
| Long return visit (40+ min) | 36 | $4,580 | $109 |
| Test to measure rate of airflow | 96 | $3,481 | $33 |
| Test to examine how well the lungs exchange gases | 64 | $3,391 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 43 | $3,320 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,951 | $60 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 16 | $1,842 | $108 |
| Test to determine lung volumes using sensors | 36 | $1,789 | $46 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,536 | $96 |
| Short return visit (20+ min) | 13 | $1,053 | $62 |
| Test to measure largest amount of air breathed in an out | 32 | $556 | $17 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 11 | $513 | $47 |
2019: 17 services
| Return visit (30+ min) | 201 | $33,636 | $84 |
| Critical care, first 30-74 minutes | 77 | $22,243 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $15,296 | $87 |
| New patient visit (60+ min) | 64 | $11,005 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,090 | $165 |
| Long return visit (40+ min) | 62 | $7,973 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $7,781 | $61 |
| Test to measure rate of airflow | 119 | $4,932 | $34 |
| Test to examine how well the lungs exchange gases | 89 | $4,811 | $48 |
| Test to measure largest amount of air breathed in an out | 118 | $3,479 | $24 |
| Test to determine lung volumes using sensors | 54 | $2,973 | $50 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 24 | $2,573 | $107 |
| Sleep study in sleep lab (6 years or older) | 20 | $2,063 | $103 |
| Short return visit (20+ min) | 21 | $1,686 | $65 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,517 | $101 |
| Insertion of tube into vena cava | 11 | $968 | $88 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 12 | $950 | $79 |
2018: 13 services
| Return visit (30+ min) | 200 | $37,798 | $85 |
| Critical care, first 30-74 minutes | 61 | $19,991 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $14,505 | $88 |
| New patient visit (60+ min) | 65 | $11,135 | $171 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,392 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $7,837 | $58 |
| Test to examine how well the lungs exchange gases | 97 | $4,985 | $47 |
| Test to measure rate of airflow | 112 | $4,674 | $34 |
| Long return visit (40+ min) | 39 | $4,589 | $104 |
| Test to measure largest amount of air breathed in an out | 110 | $3,274 | $24 |
| Test to determine lung volumes using sensors | 45 | $2,160 | $44 |
| Short return visit (20+ min) | 17 | $1,389 | $63 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $1,145 | $104 |
2017: 15 services
| Return visit (30+ min) | 206 | $33,374 | $82 |
| Critical care, first 30-74 minutes | 79 | $22,746 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $15,144 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $10,942 | $60 |
| New patient visit (60+ min) | 60 | $9,845 | $164 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,618 | $160 |
| Test to examine how well the lungs exchange gases | 86 | $4,475 | $48 |
| Test to measure rate of airflow | 111 | $4,206 | $34 |
| Long return visit (40+ min) | 28 | $3,859 | $124 |
| Test to measure largest amount of air breathed in an out | 111 | $2,791 | $23 |
| Test to determine lung volumes using sensors | 41 | $1,890 | $46 |
| Short return visit (20+ min) | 22 | $1,841 | $61 |
| Sleep study in sleep lab (6 years or older) | 15 | $1,454 | $97 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 17 | $1,267 | $70 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $1,120 | $102 |
2016: 15 services
| Return visit (30+ min) | 169 | $28,405 | $84 |
| Critical care, first 30-74 minutes | 69 | $17,674 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $13,362 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,353 | $161 |
| New patient visit (60+ min) | 60 | $9,325 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $8,850 | $59 |
| Test to measure rate of airflow | 111 | $4,552 | $34 |
| Test to examine how well the lungs exchange gases | 82 | $4,165 | $45 |
| Test to measure largest amount of air breathed in an out | 110 | $2,908 | $23 |
| Test to determine lung volumes using sensors | 48 | $2,355 | $46 |
| Short return visit (20+ min) | 33 | $2,083 | $60 |
| Insertion of tube into vena cava | 17 | $1,874 | $99 |
| Long return visit (40+ min) | 15 | $1,867 | $124 |
| New patient visit (45+ min) | 13 | $1,837 | $141 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 13 | $1,386 | $107 |
2015: 13 services
| Return visit (30+ min) | 176 | $31,175 | $86 |
| Critical care, first 30-74 minutes | 86 | $29,684 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $14,477 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $10,859 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $10,189 | $60 |
| New patient visit (60+ min) | 55 | $9,414 | $171 |
| Test to examine how well the lungs exchange gases | 94 | $4,912 | $49 |
| Test to measure rate of airflow | 125 | $4,907 | $33 |
| Test to measure largest amount of air breathed in an out | 122 | $3,154 | $22 |
| Test to determine lung volumes using sensors | 54 | $2,815 | $47 |
| Short return visit (20+ min) | 32 | $2,326 | $60 |
| Insertion of tube into vena cava | 18 | $1,812 | $101 |
| Long return visit (40+ min) | 15 | $1,743 | $116 |
2014: 14 services
| Critical care, first 30-74 minutes | 101 | $37,205 | $185 |
| Return visit (30+ min) | 189 | $30,425 | $84 |
| New patient visit (60+ min) | 60 | $9,917 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,273 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $8,373 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $7,904 | $87 |
| Test to examine how well the lungs exchange gases | 96 | $5,107 | $49 |
| Test to measure rate of airflow | 125 | $4,982 | $34 |
| Test to determine lung volumes using sensors | 73 | $3,747 | $48 |
| Test to measure largest amount of air breathed in an out | 124 | $3,144 | $22 |
| Short return visit (20+ min) | 32 | $2,234 | $57 |
| Long return visit (40+ min) | 18 | $2,230 | $117 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,823 | $107 |
| Insertion of tube into vena cava | 13 | $1,229 | $95 |
2013: 13 services
| Critical care, first 30-74 minutes | 70 | $26,425 | $176 |
| Return visit (30+ min) | 150 | $23,623 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $10,893 | $83 |
| New patient visit (60+ min) | 59 | $9,666 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $8,331 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,875 | $160 |
| Test to examine how well the lungs exchange gases | 100 | $6,381 | $53 |
| Test to measure rate of airflow | 125 | $5,493 | $34 |
| Test to determine lung volumes using sensors | 62 | $3,760 | $54 |
| Test to measure largest amount of air breathed in an out | 121 | $3,476 | $23 |
| Short return visit (20+ min) | 38 | $2,866 | $57 |
| Insertion of tube into vena cava | 11 | $1,091 | $91 |
| Test to measure oxygen level in blood using ear or finger device | 41 | $119 | $3 |
Drugs they prescribed that Part D paid
$578,863
Pharmacies billed $578,863 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,092) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
0 generic and 549 brand-name prescriptions · $578,863 in drug cost · 55 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 20 | $261,638 | $13,082 |
| Trelegy Ellipta | 171 | $134,946 | $789 |
| Anoro Ellipta | 72 | $41,485 | $576 |
| Breo Ellipta | 79 | $35,762 | $453 |
| Stiolto Respimat | 19 | $11,881 | $625 |
See all 23 drugs
| Ofev | 20 | $261,638 | $13,082 |
| Trelegy Ellipta | 171 | $134,946 | $789 |
| Anoro Ellipta | 72 | $41,485 | $576 |
| Breo Ellipta | 79 | $35,762 | $453 |
| Stiolto Respimat | 19 | $11,881 | $625 |
| Eliquis | 18 | $10,303 | $572 |
| Spiriva Respimat | 15 | $9,533 | $636 |
| Arnuity Ellipta | 22 | $7,268 | $330 |
| Wixela Inhub | 39 | $5,092 | $131 |
| Albuterol Sulfate Hfa | 161 | $3,400 | $21 |
| Fluticasone-Salmeterol | 19 | $2,648 | $139 |
| Symbicort | 11 | $2,554 | $232 |
| Roflumilast | 15 | $1,781 | $119 |
| Azelastine | 49 | $1,078 | $22 |
| Ethambutol | 11 | $989 | $90 |
| Ventolin Hfa | 14 | $880 | $63 |
| Modafinil | 33 | $699 | $21 |
| Azithromycin | 37 | $333 | $9 |
| Prednisone | 57 | $316 | $6 |
| Clonazepam | 28 | $161 | $6 |
| Zolpidem | 32 | $161 | $5 |
| Montelukast | 20 | $149 | $7 |
| Pramipexole Dihydrochloride | 24 | $97 | $4 |
Year by year
| 2024 | 1,092 | 219 | 0% (0) | 50% | $578,863 |
| 2023 | 941 | 217 | 0% (0) | 55% | $563,612 |
| 2022 | 980 | 222 | 0% (0) | 58% | $517,352 |
| 2021 | 1,109 | 241 | None | 63% | $489,219 |
| 2020 | 1,062 | 221 | None | 61% | $330,537 |
| 2019 | 1,013 | 224 | None | 62% | $294,430 |
| 2018 | 825 | 178 | None | 63% | $218,931 |
| 2017 | 685 | 155 | 0% (0) | 66% | $155,413 |
| 2016 | 585 | 151 | 0% (0) | 62% | $193,039 |
| 2015 | 650 | 148 | None | 64% | $171,387 |
| 2014 | 643 | 145 | None | 67% | $129,447 |
| 2013 | 573 | 129 | None | 68% | $106,141 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Ofev | 21 | $284,910 | $13,567 |
| Trelegy Ellipta | 101 | $89,043 | $882 |
| Anoro Ellipta | 53 | $37,381 | $705 |
| Breo Ellipta | 63 | $34,694 | $551 |
| Symbicort | 44 | $24,406 | $555 |
| Advair Diskus | 33 | $14,918 | $452 |
| Stiolto Respimat | 12 | $9,600 | $800 |
| Incruse Ellipta | 18 | $9,038 | $502 |
| Arnuity Ellipta | 29 | $8,046 | $277 |
| Wixela Inhub | 33 | $5,255 | $159 |
| Albuterol Sulfate Hfa | 137 | $5,237 | $38 |
| Budesonide-Formoterol | 11 | $4,725 | $430 |
| Fluticasone-Salmeterol | 17 | $4,369 | $257 |
| Ventolin Hfa | 16 | $1,113 | $70 |
| Modafinil | 18 | $696 | $39 |
| Azelastine | 34 | $685 | $20 |
| Prednisone | 62 | $586 | $9 |
| Montelukast | 29 | $546 | $19 |
| Azithromycin | 39 | $514 | $13 |
| Ipratropium | 11 | $314 | $29 |
| Pramipexole Dihydrochloride | 11 | $65 | $6 |
| Zolpidem | 12 | $38 | $3 |
| Alprazolam | 11 | $15 | $1 |
2022: 22 drugs
| Ofev | 14 | $183,660 | $13,119 |
| Trelegy Ellipta | 109 | $98,252 | $901 |
| Anoro Ellipta | 77 | $45,711 | $594 |
| Breo Ellipta | 65 | $37,462 | $576 |
| Stiolto Respimat | 26 | $19,000 | $731 |
| Symbicort | 25 | $14,205 | $568 |
| Spiriva Handihaler | 21 | $14,092 | $671 |
| Wixela Inhub | 42 | $12,960 | $309 |
| Eliquis | 16 | $12,517 | $782 |
| Spiriva Respimat | 18 | $12,442 | $691 |
| Arnuity Ellipta | 29 | $10,063 | $347 |
| Advair Diskus | 16 | $9,981 | $624 |
| Incruse Ellipta | 24 | $8,940 | $373 |
| Albuterol Sulfate Hfa | 135 | $7,821 | $58 |
| Budesonide-Formoterol | 13 | $6,640 | $511 |
| Fluticasone-Salmeterol | 31 | $4,484 | $145 |
| Azelastine | 35 | $1,434 | $41 |
| Prednisone | 100 | $854 | $9 |
| Montelukast | 37 | $716 | $19 |
| Azithromycin | 25 | $437 | $17 |
| Alendronate | 11 | $164 | $15 |
| Sulfamethoxazole-Trimethoprim | 12 | $98 | $8 |
2021: 22 drugs
| Ofev | 12 | $142,065 | $11,839 |
| Anoro Ellipta | 120 | $69,352 | $578 |
| Trelegy Ellipta | 80 | $57,791 | $722 |
| Breo Ellipta | 92 | $48,232 | $524 |
| Spiriva | 32 | $23,165 | $724 |
| Symbicort | 33 | $19,792 | $600 |
| Incruse Ellipta | 40 | $18,974 | $474 |
| Wixela Inhub | 49 | $14,731 | $301 |
| Advair Diskus | 18 | $13,049 | $725 |
| Spiriva Respimat | 16 | $9,332 | $583 |
| Albuterol Sulfate Hfa | 154 | $8,881 | $58 |
| Daliresp | 20 | $8,102 | $405 |
| Fluticasone-Salmeterol | 28 | $6,685 | $239 |
| Arnuity Ellipta | 24 | $5,667 | $236 |
| Azelastine | 32 | $1,503 | $47 |
| Montelukast | 61 | $1,241 | $20 |
| Ventolin Hfa | 15 | $1,127 | $75 |
| Prednisone | 83 | $726 | $9 |
| Alendronate | 23 | $154 | $7 |
| Azithromycin | 12 | $130 | $11 |
| Sulfamethoxazole-Trimethoprim | 21 | $55 | $3 |
| Levofloxacin | 14 | $46 | $3 |
2020: 25 drugs
| Anoro Ellipta | 111 | $55,042 | $496 |
| Breo Ellipta | 67 | $37,701 | $563 |
| Spiriva | 45 | $31,969 | $710 |
| Symbicort | 43 | $31,476 | $732 |
| Trelegy Ellipta | 43 | $26,828 | $624 |
| Incruse Ellipta | 59 | $24,842 | $421 |
| Advair Diskus | 30 | $19,871 | $662 |
| Wixela Inhub | 46 | $14,378 | $313 |
| Eliquis | 12 | $10,394 | $866 |
| Budesonide-Formoterol | 20 | $9,085 | $454 |
| Fluticasone-Salmeterol | 24 | $5,027 | $209 |
| Albuterol Sulfate Hfa | 86 | $4,716 | $55 |
| Pramipexole Er | 12 | $4,332 | $361 |
| Arnuity Ellipta | 18 | $4,247 | $236 |
| Ventolin Hfa | 55 | $4,207 | $76 |
| Ipratropium | 18 | $951 | $53 |
| Montelukast | 52 | $847 | $16 |
| Azelastine | 22 | $733 | $33 |
| Prednisone | 76 | $670 | $9 |
| Modafinil | 15 | $523 | $35 |
| Alendronate | 27 | $284 | $11 |
| Azithromycin | 19 | $201 | $11 |
| Sulfamethoxazole-Trimethoprim | 20 | $158 | $8 |
| Zolpidem | 14 | $91 | $7 |
| Levofloxacin | 15 | $73 | $5 |
2019: 23 drugs
| Spiriva | 62 | $39,432 | $636 |
| Anoro Ellipta | 81 | $38,021 | $469 |
| Breo Ellipta | 71 | $37,884 | $534 |
| Symbicort | 49 | $27,640 | $564 |
| Trelegy Ellipta | 50 | $27,548 | $551 |
| Incruse Ellipta | 47 | $23,187 | $493 |
| Advair Diskus | 40 | $20,273 | $507 |
| Spiriva Respimat | 15 | $8,999 | $600 |
| Wixela Inhub | 28 | $8,942 | $319 |
| Arnuity Ellipta | 26 | $5,224 | $201 |
| Proair Hfa | 39 | $3,879 | $99 |
| Ventolin Hfa | 40 | $2,690 | $67 |
| Fluticasone-Salmeterol | 13 | $1,909 | $147 |
| Albuterol Sulfate Hfa | 15 | $852 | $57 |
| Prednisone | 100 | $808 | $8 |
| Azelastine | 22 | $802 | $36 |
| Modafinil | 18 | $653 | $36 |
| Montelukast | 25 | $531 | $21 |
| Azithromycin | 26 | $321 | $12 |
| Alendronate | 23 | $208 | $9 |
| Sulfamethoxazole-Trimethoprim | 12 | $126 | $10 |
| Zolpidem | 21 | $65 | $3 |
| Furosemide | 13 | $57 | $4 |
2018: 20 drugs
| Advair Diskus | 75 | $50,631 | $675 |
| Breo Ellipta | 75 | $31,834 | $424 |
| Anoro Ellipta | 61 | $30,447 | $499 |
| Spiriva | 48 | $27,666 | $576 |
| Incruse Ellipta | 50 | $22,243 | $445 |
| Symbicort | 27 | $12,123 | $449 |
| Trelegy Ellipta | 17 | $8,237 | $485 |
| Chantix | 11 | $4,479 | $407 |
| Ventolin Hfa | 59 | $3,274 | $55 |
| Proair Hfa | 33 | $2,647 | $80 |
| Arnuity Ellipta | 11 | $1,894 | $172 |
| Modafinil | 15 | $1,012 | $67 |
| Azelastine | 21 | $877 | $42 |
| Prednisone | 110 | $874 | $8 |
| Montelukast | 24 | $361 | $15 |
| Amoxicillin-Clavulanate Potass | 18 | $216 | $12 |
| Alendronate | 14 | $208 | $15 |
| Cefuroxime | 14 | $180 | $13 |
| Azithromycin | 20 | $140 | $7 |
| Trazodone | 22 | $122 | $6 |
2017: 13 drugs
| Advair Diskus | 68 | $34,724 | $511 |
| Spiriva | 59 | $30,080 | $510 |
| Anoro Ellipta | 57 | $22,096 | $388 |
| Breo Ellipta | 43 | $15,709 | $365 |
| Incruse Ellipta | 35 | $14,248 | $407 |
| Symbicort | 34 | $10,952 | $322 |
| Spiriva Respimat | 19 | $6,916 | $364 |
| Proair Hfa | 43 | $3,607 | $84 |
| Ventolin Hfa | 59 | $3,115 | $53 |
| Modafinil | 26 | $1,657 | $64 |
| Prednisone | 69 | $518 | $8 |
| Montelukast | 35 | $480 | $14 |
| Azithromycin | 21 | $134 | $6 |
2016: 12 drugs
| Spiriva | 102 | $40,243 | $395 |
| Advair Diskus | 80 | $33,856 | $423 |
| Symbicort | 41 | $13,807 | $337 |
| Proair Hfa | 55 | $3,792 | $69 |
| Breo Ellipta | 12 | $3,605 | $300 |
| Ventolin Hfa | 13 | $724 | $56 |
| Prednisone | 70 | $687 | $10 |
| Montelukast | 18 | $172 | $10 |
| Levofloxacin | 13 | $125 | $10 |
| Alendronate | 12 | $108 | $9 |
| Azithromycin | 11 | $80 | $7 |
| Trazodone | 15 | $75 | $5 |
2015: 10 drugs
| Spiriva | 139 | $50,816 | $366 |
| Advair Diskus | 50 | $19,088 | $382 |
| Symbicort | 55 | $17,335 | $315 |
| Foradil | 18 | $6,918 | $384 |
| Proair Hfa | 69 | $4,568 | $66 |
| Prednisone | 76 | $786 | $10 |
| Theophylline Anhydrous | 23 | $487 | $21 |
| Montelukast | 15 | $456 | $30 |
| Azithromycin | 19 | $202 | $11 |
| Levofloxacin | 13 | $167 | $13 |
2014: 13 drugs
| Spiriva | 122 | $45,673 | $374 |
| Advair Diskus | 75 | $26,855 | $358 |
| Symbicort | 36 | $13,162 | $366 |
| Foradil | 23 | $6,913 | $301 |
| Proair Hfa | 68 | $4,720 | $69 |
| Combivent Respimat | 15 | $4,183 | $279 |
| Dulera | 14 | $3,983 | $285 |
| Fluconazole | 11 | $1,917 | $174 |
| Prednisone | 87 | $617 | $7 |
| Theophylline Anhydrous | 18 | $466 | $26 |
| Azithromycin | 16 | $356 | $22 |
| Levofloxacin | 12 | $153 | $13 |
| Clonazepam | 11 | $72 | $7 |
2013: 14 drugs
| Spiriva | 129 | $39,220 | $304 |
| Advair Diskus | 57 | $16,909 | $297 |
| Symbicort | 47 | $15,153 | $322 |
| Foradil | 23 | $4,992 | $217 |
| Dulera | 16 | $4,076 | $255 |
| Combivent Respimat | 15 | $3,955 | $264 |
| Daliresp | 11 | $3,539 | $322 |
| Proair Hfa | 42 | $2,141 | $51 |
| Montelukast | 14 | $1,634 | $117 |
| Azithromycin | 11 | $807 | $73 |
| Ventolin Hfa | 12 | $506 | $42 |
| Prednisone | 79 | $495 | $6 |
| Ropinirole | 17 | $337 | $20 |
| Clonazepam | 11 | $72 | $7 |
Money from drug and device companies
$357 in 2025
| 2025 | 7 | 10 | None | $357 |
| 2024 | 3 | 4 | None | $162 |
| 2023 | 4 | 9 | None | $357 |
| 2022 | 4 | 4 | None | $110 |
| 2021 | 3 | 5 | None | $92 |
| 2020 | 1 | 2 | None | $28 |
| 2019 | 4 | 13 | None | $196 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $121 | 1 payment
|
| Inspire Medical Systems | Inspire | $87 | 4 payments
|
| United Therapeutics | Tyvaso | $33 | 1 payment
|
| Amgen | Tezspire | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $29 | 1 payment
|
| Lilly USA | Zepbound | $28 | 1 payment
|
See all 10 published payments
| United Therapeutics | Meals · 2025-09-29 | Tyvaso | $33 |
| Intuitive Surgical | Meals · 2025-09-23 | Da Vinci Surgical System | $121 |
| Insmed | Meals · 2025-09-16 | Arikayce | $25 |
| Inspire Medical Systems | Meals · 2025-09-09 | Inspire | $15 |
| Amgen | Meals · 2025-07-28 | Tezspire | $33 |
| Inspire Medical Systems | Meals · 2025-06-11 | Inspire | $42 |
| Inspire Medical Systems | Meals · 2025-05-19 | Inspire | $16 |
| Lilly USA | Meals · 2025-03-18 | Zepbound | $28 |
| Inspire Medical Systems | Meals · 2025-02-11 | Inspire | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-03 | Ofev | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $162
| Inspire Medical Systems | Inspire | $99 | 2 payments
|
| Genzyme | Dupixent | $33 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $31 | 1 payment
|
2023: $357
| Inspire Medical Systems | Inspire | $165 | 6 payments
|
| Actelion Pharmaceuticals US | Uptravi | $141 | 1 payment
|
| United Therapeutics | Tyvaso | $34 | 1 payment
|
| Amgen | Tezspire | $17 | 1 payment
|
2022: $110
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $38 | 1 payment
|
| Electromed | Smartvest | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $26 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $13 | 1 payment
|
2021: $92
| Insmed | Arikayce | $44 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $36 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $11 | 1 payment
|
2020: $28
| GlaxoSmithKline | Anoro Ellipta | $28 | 2 payments
|
2019: $196
| GlaxoSmithKline | Anoro | $118 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $34 | 1 payment
|
| Insmed | Arikayce | $24 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $21 | 1 payment
|
Checkups this office reported
11 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 85.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 277 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 118 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 0%That's few of the people this applied to. | 66 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 362 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 23% | 30 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 505 |
| HIV screeningEligible patients who were screened for HIV | 0%That's few of the people this applied to. | 156 |
| Medications listed in the chartVisits where the current medication list was documented | 81%That's most of the people this applied to. | 1,054 |
See the other 3 measures
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 2%That's few of the people this applied to. Better on this measure. | 377 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 17% | 854 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 18%That's few of the people this applied to. | 486 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Uses standard treatment protocols
Professional record
- NPI
- 1841270584
- Licence
- CA A102199, KS 0430219California A102199: Current · expires 2027-03-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- KS 200002730A
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 168 N Brent St, Suite 406, Ventura, CA, 93003
- NPI first listed
- 2006-01-19
- NPI last updated
- 2023-05-11
- NPI record certified
- 2023-05-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Hillmont Ave, Ventura, CA, 93003
This office lists an electronic records connection.